These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8865269

  • 1. Protracted levamisole in children with frequent-relapse nephrotic syndrome.
    Ginevri F, Trivelli A, Ciardi MR, Ghiggeri GM, Parfumo F, Gusmano R.
    Pediatr Nephrol; 1996 Aug; 10(4):550. PubMed ID: 8865269
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levamisole therapy in nephrotic syndrome.
    Srivastava RN.
    Pediatr Nephrol; 1999 Sep; 13(7):636. PubMed ID: 10507834
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
    Sümegi V, Haszon I, Iványi B, Bereczki C, Papp F, Túri S.
    Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P, Bianchetti MG, Imoberdorf G, Lütschg J, Reymond D, Oetliker OH.
    Schweiz Med Wochenschr; 1994 May 14; 124(19):801-5. PubMed ID: 8209202
    [Abstract] [Full Text] [Related]

  • 11. [Levamisole in the treatment of nephrotic syndrome].
    García Soto L, Miranda Romera P, Vintimilla Andrade JE, Gómez Llorente MA, de Diego Fernández P.
    An Pediatr (Engl Ed); 2020 Mar 14; 92(3):168-169. PubMed ID: 31151760
    [No Abstract] [Full Text] [Related]

  • 12. Is there a contraindication for polio vaccination in children who are treated with levamisole?
    Blanche S.
    Pediatr Nephrol; 2000 Sep 14; 14(10-11):1059. PubMed ID: 10975326
    [No Abstract] [Full Text] [Related]

  • 13. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome.
    Barbano G, Ginevri F, Ghiggeri GM, Gusmano R.
    Pediatr Nephrol; 1999 Sep 14; 13(7):602-3. PubMed ID: 10460511
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K, Mirza K, Al-Ghanam G, Abdelkarim M.
    Pediatr Nephrol; 2006 Feb 14; 21(2):201-5. PubMed ID: 16222548
    [Abstract] [Full Text] [Related]

  • 16. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F, Ahmed TM, Samina U.
    J Coll Physicians Surg Pak; 2006 Jan 14; 16(1):35-7. PubMed ID: 16441986
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome.
    Kreeftmeijer-Vegter AR, Dorlo TP, Gruppen MP, de Boer A, de Vries PJ.
    Br J Clin Pharmacol; 2015 Aug 14; 80(2):242-52. PubMed ID: 25677380
    [Abstract] [Full Text] [Related]

  • 18. Levamisole therapy in corticosteroid-dependent nephrotic syndrome.
    Bagga A, Sharma A, Srivastava RN.
    Pediatr Nephrol; 1997 Aug 14; 11(4):415-7. PubMed ID: 9260236
    [Abstract] [Full Text] [Related]

  • 19. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
    Pediatr Nephrol; 2002 May 14; 17(5):355-8. PubMed ID: 12042893
    [Abstract] [Full Text] [Related]

  • 20. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov 14; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.